Effects of tibolone on the endometrium
article
OA: closed
CC0
⤵ 5 in-corpus citations
Abstract
OBJECTIVE: To investigate the effects of 24 months of tibolone treatment on the endometrium in postmenopausal women. DESIGN: An open, prospective, multicenter study with a treatment duration of 24 months. POPULATION: One hundred and fifty healthy postmenopausal women. METHODS: Women were treated with one tablet of tibolone (2.5 mg Org OD14) daily. Endometrial biopsies were taken at baseline, 12 months (n = 112) and 24 months (n = 62) to investigate endometrial histology by means of light microscopy. RESULTS: No stimulation of atrophic endometrium was observed in 98.2% and 91.9% of the analyzed women after 12 and 24 months, respectively. A change from an atrophic endometrial pattern to a weakly proliferative pattern was seen in 1.8% (95% confidence interval (CI) 0.22-6.45) and 6.5% (95% CI 1.20-7.51) of the women after 12 and 24 months, respectively. In one woman, the endometrial pattern after 24 months was classified as simple hyperplasia (1.6%; 95% CI 0.01-3.20). The low incidence of proliferation and/or hyperplasia corresponds to that seen in other clinical trials in which women have been treated with placebo. Vaginal bleeding and/or spotting was reported by 18 women (12%), all showing an atrophic endometrium at all assessments, except for one woman with a proliferative endometrium at 24 months. CONCLUSION: In the majority of women (92%), the endometrium remained atrophic during 24 months of tibolone treatment.
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (27)
- Effects of two doses of tibolone on trabecular and cortical bone loss in early postmenopausal women: A two-year randomized, placebo-controlled study via openalex
- Endometrial Safety During Hormone Replacement Therapy via openalex
- Immunohistochemical localization of acidic and basic fibroblast growth factors in normal human endometrium and endometriosis and the detection of their mRNA by polymerase chain reaction via openalex
- Long term effects of tibolone on the genital tract in postmenopausal women via openalex
- Org OD 14 and the endometrium via openalex
- Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. via openalex
- doi:10.1002/jcp.1041370329 via openalex
- doi:10.1016/0022-4731(90)90196-y via openalex
- doi:10.3109/09513599909167560 via openalex
- doi:10.1111/j.1471-0528.1994.tb13085.x via openalex
- doi:10.1016/s0010-7824(86)80016-6 via openalex
- doi:10.1016/0378-5122(95)00953-1 via openalex
- doi:10.1210/jcem.81.7.8675554 via openalex
- doi:10.1111/j.1471-0528.1998.tb10237.x via openalex
- doi:10.1016/0960-0760(93)90003-f via openalex
- doi:10.1016/0378-5122(96)01206-6 via openalex
- doi:10.1136/bmj.280.6225.1207 via openalex
- W2228748116 via openalex
- W2413783771 via openalex
- doi:10.1111/j.1471-0528.1994.tb13010.x via openalex
- doi:10.1016/s0378-5122(96)01070-5 via openalex
- doi:10.1111/j.1471-0528.1995.tb09066.x via openalex
- doi:10.1016/s0378-5122(97)00037-6 via openalex
- doi:10.1016/0378-5122(84)90023-9 via openalex
- doi:10.1111/j.1471-0528.2000.tb11654.x via openalex
- doi:10.1016/s0015-0282(16)58390-3 via openalex
- doi:10.1016/0378-5122(87)90040-5 via openalex
Cited by (5)
- Aging of the endometrium 2008
- Histological and immunohistochemical evaluation of postmenopausal endometrium after 3 weeks of treatment with tibolone, estrogen only, or estrogen plus progestagen 2006
- A 5-year study on the effect of hormone therapy, tibolone and raloxifene on vaginal bleeding and endometrial thickness 2005
- GnRH analogs for the treatment of symptomatic uterine leiomyomas 2005
- Endometrial assessment in women using tibolone or placebo: 1-year randomized trial and 2-year observational study 2004
Source provenance
- openalex
- last seen: 2026-05-11T03:14:23.695217+00:00
License: CC0
· commercial use OK